Thrombolytic Science International's Unattributed Round

Thrombolytic Science International raised a round of funding on January 13, 2012.

Thrombolytic Science International is focused on developing M5, a mutant of pro-urokinase (proUK). M5 is a thrombolytic that follows a different paradigm than tPA, has superior efficacy and is accomp…

Articles about Thrombolytic Science International's Unattributed Round: